Streetbeat News

Regulatory

BYFC

Broadway Financial has received a notice from Nasdaq concerning its failure to file Form 10-K, a required annual report. This notice could potentially lead to Broadway Financial's delisting if the issue is not resolved promptly. The company is likely working on addressing the filing requirements to maintain its listing status.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 8:46 pm

VCXB

10X Capital Venture Acquisition Corp. III has received a notice from the NYSE for failing to file its Form 10-K on time. This notice is a standard procedure for companies that do not meet the NYSE's filing deadlines. The company is expected to address this issue promptly to remain in compliance with NYSE listing requirements.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 8:44 pm

BIMI

BIMI International Medical has received a delinquency compliance alert notice from Nasdaq, indicating potential issues with meeting the exchange's listing requirements.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 8:39 pm

RGF

The Real Good Food Company, Inc. (RGF) has received a notice from Nasdaq regarding its failure to meet the minimum bid price requirement. The company's stock has been trading below $1.00 for a consecutive 30-day period, which is against Nasdaq's listing rules. RGF now has a compliance period of 180 days to regain compliance by having its stock close at or above $1.00 for a minimum of ten consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 8:37 pm

DRCT

Direct Digital Holdings has received a notification from Nasdaq regarding non-compliance with listing requirements. The specifics of the non-compliance were not detailed, but such notifications typically relate to financial standards, governance practices, or share price minimums. The company will likely have a grace period to regain compliance, during which it must meet Nasdaq's requirements to avoid potential delisting.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 8:22 pm

TRIS

Tristar Acquisition I Corp. has received a notice from the NYSE for failing to file its Form 10-K on time. This notice is a standard procedure for companies that do not meet the NYSE's filing deadlines. The company is expected to address this issue promptly to remain in compliance with NYSE listing requirements.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 8:12 pm

MEDS

TRxADE Health, Inc. has received a notice from Nasdaq due to the late filing of its annual report on Form 10-K. This notice is a standard procedure for companies that fail to meet Nasdaq's filing deadlines, and it may impact the company's listing status if the issue is not resolved in a timely manner. TRxADE Health is likely working to address the filing delay and maintain compliance with Nasdaq's listing requirements.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 8:10 pm

TSLA

Tesla reported that its profitability was affected by a reduced Average Selling Price (ASP) due to pricing and mix changes, an increase in operating expenses (Opex), and a decline in vehicle deliveries. However, these negative impacts were partially offset by a lower cost per vehicle, higher Full Self-Driving (FSD) revenue recognition, and benefits from the Inflation Reduction Act (IRA) credit.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 8:08 pm

DAWN

Day One's OJEMDA has received accelerated approval from the U.S. FDA for treating relapsed or refractory pediatric low-grade glioma (pLGG) with BRAF alterations. It's the first FDA-approved type II RAF inhibitor for this condition, showing a 51% overall response rate in the RAPNO LGG study. Day One also received a rare pediatric disease priority review voucher. A conference call and webcast are scheduled for April 24, 8:30 a.m. Eastern Time.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 7:58 pm

WORX

SCWorx Corp. has received a notice from NASDAQ regarding its failure to file the Form 10-K for the fiscal year ending December 31, 2023. This notice could potentially lead to SCWorx's delisting from the NASDAQ if the company does not remedy the filing deficiency within the given timeframe.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 7:45 pm